Sastasundar Ventures Rebrands to Health X Platform, Trading Symbol HEALTHX Effective April 30, 2026

Effective April 30, 2026, Sastasundar Ventures Limited will officially trade as Health X Platform Limited, using the new stock symbol HEALTHX on both the BSE and NSE. This corporate rebranding signals the company's strategic evolution into a broader digital health ecosystem provider.

Regulatory Approval Secured for Name Change

Sastasundar Ventures Limited has received formal approval from the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) to change its corporate name to Health X Platform Limited. This change is scheduled to take effect on April 30, 2026. Following this, the company's trading symbol on both exchanges will be updated to 'HEALTHX'.

Strategic Shift to Digital Health Ecosystem

The renaming underscores the company's strategic pivot towards establishing itself as a comprehensive digital health platform and ecosystem. This move aligns its market presence with its evolving business model and future growth ambitions within the healthcare technology sector.

Company Evolution and Shareholder Approval

Sastasundar Ventures Limited has been undergoing a significant strategic transformation. This rebranding follows a period of internal restructuring and the in-principle approval for merging its subsidiary, Sastasundar Healthbuddy Limited (SHBL), into the parent company. Shareholders overwhelmingly approved the name change and the strategic expansion into healthcare and digital platforms earlier in 2026. The company has historically operated in the e-pharmacy and diagnostic services sectors, with a focus on building a comprehensive digital healthcare network.

Impact on Shareholders and Trading

For shareholders, the most visible change will be the listed entity's updated identity. Share trading will commence under the new name 'Health X Platform Limited' and the ticker symbol 'HEALTHX' beginning April 30, 2026. The company's corporate identification number and overall legal status will remain unaffected by this rebranding.

Investor Considerations: Past Performance and Recent Turnaround

While this is primarily a rebranding initiative, investors may remember previous periods of financial volatility, including declines in net sales and operating losses. However, recent financial results for Q3 FY26 have indicated a positive turnaround, marked by revenue growth and reduced losses, suggesting improved operational performance. The company's filing did not identify any new significant risks directly tied to the name change itself.

Market Position and Key Competitors

Health X Platform operates within India's rapidly expanding health technology sector. Key competitors include major players like API Holdings (PharmEasy), Apollo Hospitals (Apollo 24/7), Netmeds, and Tata 1mg. These companies are similarly focused on expanding their digital health offerings and e-pharmacy services.

Future Focus for Investors

Investors should monitor the company's stock trading activity under the new symbol 'HEALTHX' commencing April 30, 2026. Observing the market's reaction and how the new identity influences future business developments and financial reporting will be key. Further updates on the proposed merger of SHBL integration should also be watched.